PT917879E - Processo melhorado para estabilizacao de proteinas - Google Patents

Processo melhorado para estabilizacao de proteinas

Info

Publication number
PT917879E
PT917879E PT98121684T PT98121684T PT917879E PT 917879 E PT917879 E PT 917879E PT 98121684 T PT98121684 T PT 98121684T PT 98121684 T PT98121684 T PT 98121684T PT 917879 E PT917879 E PT 917879E
Authority
PT
Portugal
Prior art keywords
improved process
protein stabilization
stabilization
protein
improved
Prior art date
Application number
PT98121684T
Other languages
English (en)
Inventor
Winter Prof Dr Gerhard
Klaus Hellerbrand
Apollon Papadimitriou
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26145913&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT917879(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of PT917879E publication Critical patent/PT917879E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/963—Methods of stopping an enzyme reaction or stabilizing the test materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT98121684T 1997-11-22 1998-11-13 Processo melhorado para estabilizacao de proteinas PT917879E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97120528 1997-11-22
EP98102846 1998-02-19

Publications (1)

Publication Number Publication Date
PT917879E true PT917879E (pt) 2002-12-31

Family

ID=26145913

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98121684T PT917879E (pt) 1997-11-22 1998-11-13 Processo melhorado para estabilizacao de proteinas

Country Status (16)

Country Link
US (1) US6238664B1 (pt)
EP (1) EP0917879B1 (pt)
JP (1) JP3105494B2 (pt)
KR (1) KR100315908B1 (pt)
CN (1) CN1220270A (pt)
AR (2) AR018020A1 (pt)
AT (1) ATE220558T1 (pt)
AU (1) AU714264B2 (pt)
BR (1) BRPI9805021B8 (pt)
CA (1) CA2254145C (pt)
DE (1) DE59804785D1 (pt)
DK (1) DK0917879T3 (pt)
ES (1) ES2179414T3 (pt)
PT (1) PT917879E (pt)
TR (1) TR199802394A3 (pt)
ZA (1) ZA9810650B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
US7780967B2 (en) 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
US20030118598A1 (en) * 2000-02-08 2003-06-26 Allergan, Inc. Clostridial toxin pharmaceutical compositions
US20060269575A1 (en) * 2000-02-08 2006-11-30 Allergan, Inc. Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
US8632785B2 (en) * 2000-02-08 2014-01-21 Allergan, Inc. Clostridial toxin pharmaceutical composition containing a gelatin fragment
EP1253932B1 (en) * 2000-02-08 2005-04-27 Allergan, Inc. Botulinum toxin pharmaceutical compositions
US20140186361A1 (en) 2012-09-07 2014-07-03 Coherus Biosciences, Inc. Stable Aqueous Formulations of Adalimumab
DE10149030A1 (de) * 2001-10-05 2003-04-10 Viscum Ag Stabile galenische gefriergetrocknete Arzneimittelzubereitung von rViscumin
US20040185040A1 (en) * 2001-11-21 2004-09-23 Celltech R & D Limited Modulating immune responses
US20030175827A1 (en) * 2002-03-14 2003-09-18 Stillman Brett A. Stable thin film dried protein composition or device and related methods
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
JP4607010B2 (ja) 2003-02-28 2011-01-05 中外製薬株式会社 タンパク質含有安定化製剤
MX2008001068A (es) * 2005-07-29 2008-03-19 Amgen Inc Formulacion que inhibe la agregacion de proteina.
JP2010506839A (ja) * 2006-10-12 2010-03-04 ワイス エルエルシー 乳光の低減を伴う方法および組成物
CA2764180A1 (en) * 2009-06-18 2010-12-23 Wyeth Llc Lyophilized formulations for small modular immunopharmaceuticals
BR112017006533A2 (pt) * 2014-09-29 2017-12-19 Cook General Biotechnology Llc usos de trealose em suspensões celulares
US11229702B1 (en) 2015-10-28 2022-01-25 Coherus Biosciences, Inc. High concentration formulations of adalimumab
WO2017184880A1 (en) 2016-04-20 2017-10-26 Coherus Biosciences, Inc. A method of filling a container with no headspace
US11110063B2 (en) 2017-08-25 2021-09-07 MAIA Pharmaceuticals, Inc. Storage stable sincalide formulations
CN111781345A (zh) * 2020-06-30 2020-10-16 上海透景生命科技股份有限公司 化学发光标记物标记抗原稳定剂及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3064888D1 (en) 1979-04-30 1983-10-27 Hoechst Ag Aqueous solutions of proteins stable against denaturization, process for their manufacture, and their utilization
US4783441A (en) 1979-04-30 1988-11-08 Hoechst Aktiengesellschaft Aqueous protein solutions stable to denaturation
US4362661A (en) 1979-08-09 1982-12-07 Teijin Limited Immunoglobulin composition having a high monomer content, and process for production thereof
CA1329760C (en) 1987-10-29 1994-05-24 Ted C. K. Lee Plasma and recombinant protein formulations in high ionic strength media
GB8726136D0 (en) * 1987-11-07 1987-12-09 Wellcome Found Therapeutic nucleosides
US4877608A (en) 1987-11-09 1989-10-31 Rorer Pharmaceutical Corporation Pharmaceutical plasma protein formulations in low ionic strength media
ZA888577B (en) 1987-11-27 1989-08-30 Akzo Nv Stabilization of antibodies
GB8920534D0 (en) * 1989-09-11 1989-10-25 Wellcome Found Antiviral compounds
US5164296A (en) * 1990-08-31 1992-11-17 University Of Maryland At Baltimore Assay methods involving ouabain
DE4126983A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
RU2109290C1 (ru) * 1996-04-09 1998-04-20 Государственный научный центр вирусологии и биотехнологии "Вектор" Стабилизирующий состав для получения лиофилизированных препаратов на основе конъюгата антииммуноглобулина g и пероксидазы хрена
EP0852951A1 (de) * 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern

Also Published As

Publication number Publication date
AR018020A1 (es) 2001-10-31
EP0917879B1 (de) 2002-07-17
BRPI9805021B1 (pt) 2011-05-31
AR034226A2 (es) 2004-02-04
BRPI9805021B8 (pt) 2021-07-06
BRPI9805021A (pt) 2000-03-21
KR19990045460A (ko) 1999-06-25
CN1220270A (zh) 1999-06-23
ES2179414T3 (es) 2003-01-16
DK0917879T3 (da) 2002-11-04
DE59804785D1 (de) 2002-08-22
CA2254145A1 (en) 1999-05-22
ATE220558T1 (de) 2002-08-15
TR199802394A2 (xx) 1999-06-21
TR199802394A3 (tr) 1999-06-21
JPH11240895A (ja) 1999-09-07
AU9406098A (en) 1999-06-10
JP3105494B2 (ja) 2000-10-30
EP0917879A3 (de) 1999-06-09
AU714264B2 (en) 1999-12-23
US6238664B1 (en) 2001-05-29
EP0917879A2 (de) 1999-05-26
KR100315908B1 (ko) 2002-04-24
ZA9810650B (en) 1999-05-24
CA2254145C (en) 2002-10-08

Similar Documents

Publication Publication Date Title
PT917879E (pt) Processo melhorado para estabilizacao de proteinas
PT916675E (pt) Processo para preparacao de sildenafil
BR9504256A (pt) Processo para o preparo de composiçoes de tonalizador
PT1256584E (pt) Processo para a preparacao de adefovir-dipivoxil
BR9809112B1 (pt) processo para preparação de clopidogrel.
BR9607721A (pt) Processo para preparar compostos ciclo-hexapeptídeo
BR9606782A (pt) Processo para preparar ciclopilacetileno
PT1113965E (pt) Acessorio para gargalo de garrafa
BR9710099A (pt) Processo para produzir compostos
BR9815223B1 (pt) processo de aminação.
BR9710470A (pt) Processo para preparar caprolactama
IT1283646B1 (it) Processo di preparazione di perfluoropolieteri
BR9601294A (pt) Composto e processo para preparação do mesmo
BR9800557A (pt) Processo contínuo para preparação de 4-aminopiperidinas
BR9703537A (pt) Processo para preparação de laticínois possuindo vida útil em prateleira melhorada
PT912603E (pt) Processo para preparar certos aza ciclo-hexapeptidos
BR9706239A (pt) Processo para preparação de 3-(1-hidroxifenil-1-alcoxiimino-metil)dioxazinas
BR9700007A (pt) Processo
PT1049723E (pt) Processo para o fabrico de inulina de chicoria
BR9706596A (pt) Processo para identificação pessoal
BR9800461A (pt) Composição de revestimento de poliuretano curada por unidade e processo para sua estabilização
BR9804794A (pt) Processo para prepara-Æo de 1-alquil-4-(2-cloro-3-alcÄxi-4-alquil-sulfonil-benzoil) -5-hidrÄxi-pirazol e compostos relacioonados
PT1012152E (pt) Processo para a preparacao de oxazafosforina-2-aminas
BR9708186A (pt) Processo para preparação de tiocarboxamidas aromáticas substituídas
BR9701526A (pt) Processo para enegrecimento de agulhas cirúrgicas